FAM239B: A Zinc Finger Protein as a Potential Drug Target and Biomarker

Target Name: FAM239B

NCBI ID: G729162

FAM239B

Other Name(s): Zinc finger protein 839-like | LOC729162 | family with sequence similarity 239 member B

FAM239B: A Zinc Finger Protein as a Potential Drug Target and Biomarker

Abstract:

FAM239B, also known as zinc finger protein 839-like, is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. It is characterized by a unique zinc finger domain and is expressed in various tissues and cells throughout the body. In this article, we will discuss the characterization of FAM239B, its potential drug target properties, and its potential as a biomarker for various diseases.

Introduction:

FAM239B is a non-coding RNA molecule that is expressed in various tissues and cells throughout the body. It is characterized by a unique zinc finger domain, which is a type of non-coding RNA molecule that can interact with protein molecules and play a role in various cellular processes. Zinc finger proteins are a family of non-coding RNAs that are involved in various cellular processes, including gene regulation, DNA replication, and apoptosis. FAM239B is one of the latest additions to the zinc finger protein family and has gained significant interest due to its unique structure and potential functions.

Characterization of FAM239B:

FAM239B is a small non-coding RNA molecule that is approximately 120 amino acids long. It has a unique zinc finger domain that is composed of four conserved amino acids: alanine, glutamic acid, aspartic acid, and glycine. The zinc finger domain is responsible for the binding of proteins to the RNA molecule and is involved in various cellular processes.

FAM239B is expressed in various tissues and cells throughout the body, including the brain, heart, liver, and muscle. It is also expressed in various types of cancer, including breast, ovarian, and colorectal cancer. This suggests that FAM239B may be a potential drug target for these diseases.

Potential Drug Target Properties:

FAM239B's unique zinc finger domain and its expression in various tissues and cells make it an attractive target for drug development. The zinc finger domain is known for its ability to interact with proteins and has been implicated in various cellular processes, including cell signaling, DNA replication, and apoptosis.

FAM239B has been shown to play a role in cell signaling by regulating the expression of various genes. For example, studies have shown that FAM239B can interact with the protein Stat3 and prevent its degradation. This interaction between FAM239B and Stat3 suggests that FAM239B may be a potential drug target for diseases that are characterized by Stat3-mediated signaling pathways.

FAM239B has also been shown to be involved in DNA replication. Studies have shown that FAM239B can interact with the protein DnaC, which is involved in DNA replication. This interaction between FAM239B and DnaC suggests that FAM239B may be a potential drug target for diseases that are characterized by DNA replication disorders.

FAM239B has also been shown to be involved in apoptosis, which is a process that is responsible for cell death. Studies have shown that FAM239B can interact with the protein Bcl-2, which is involved in apoptosis. This interaction between FAM239B and Bcl-2 suggests that FAM239B may be a potential drug target for diseases that are characterized by apoptosis.

Potential Biomarker Properties:

FAM239B has the potential to serve as a biomarker for various diseases due to its unique structure and expression patterns. As previously discussed, FAM239B is expressed in various tissues and cells throughout the body and is also expressed in various types of cancer. This suggests that FAM239B may be a potential biomarker for various diseases, including cancer.

FAM239B's unique zinc finger domain and its interaction with proteins have also been shown to be involved in various cellular processes that are relevant to disease. For example, studies have shown that FAM239B can interact with the protein

Protein Name: Family With Sequence Similarity 239 Member B

The "FAM239B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FAM239B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets